These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35478205)

  • 1. Neuroprotective effect of CTK 01512-2 recombinant toxin at the spinal cord in a model of Huntington's disease.
    Joviano-Santos JV; Valadão PAC; Magalhães-Gomes MPS; Fernandes LF; Diniz DM; Machado TCG; Soares KB; Ladeira MS; Massensini AR; Gomez MV; Miranda AS; Tápia JC; Guatimosim C
    Exp Physiol; 2022 Aug; 107(8):933-945. PubMed ID: 35478205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of a spider recombinant toxin in a murine model of Huntington's disease.
    Joviano-Santos JV; Valadão PAC; Magalhães-Gomes MPS; Fernandes LF; Diniz DM; Machado TCG; Soares KB; Ladeira MS; Miranda AS; Massensini AR; Gomez MV; Guatimosim C
    Neuropeptides; 2021 Feb; 85():102111. PubMed ID: 33333486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.
    Valadão PA; de Aragão BC; Andrade JN; Magalhães-Gomes MP; Foureaux G; Joviano-Santos JV; Nogueira JC; Ribeiro FM; Tapia JC; Guatimosim C
    Eur J Neurosci; 2017 Mar; 45(6):785-796. PubMed ID: 27992085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DNA damage in spinal cord and mutagenic effect of a Phα1β recombinant toxin with analgesic properties from the Phoneutria nigriventer spider.
    de Souza AH; da Rosa LG; Uliano MR; da Silva Prado L; Ferraz AG; Conter LU; Grivicich I; Dallegrave E; Gomez MV; Picada JN
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):615-620. PubMed ID: 30449066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.
    Whittaker DS; Loh DH; Wang HB; Tahara Y; Kuljis D; Cutler T; Ghiani CA; Shibata S; Block GD; Colwell CS
    J Biol Rhythms; 2018 Oct; 33(5):535-554. PubMed ID: 30084274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
    Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
    Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Sequencing of BACHD Mice Reveals Upregulation of Neuroprotective miRNAs at the Pre-Symptomatic Stage of Huntington's Disease.
    Olmo IG; Olmo RP; Gonçalves ANA; Pires RGW; Marques JT; Ribeiro FM
    ASN Neuro; 2021; 13():17590914211009857. PubMed ID: 33906482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
    Kuljis DA; Gad L; Loh DH; MacDowell Kaswan Z; Hitchcock ON; Ghiani CA; Colwell CS
    PLoS One; 2016; 11(2):e0147583. PubMed ID: 26871695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.
    King AC; Wood TE; Rodriguez E; Parpura V; Gray M
    Exp Neurol; 2020 Aug; 330():113358. PubMed ID: 32387649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Phoneutria nigriventer spider toxin, PnTx4-5-5, promotes neuronal survival by blocking NMDA receptors.
    Silva FR; Batista EM; Gomez MV; Kushmerick C; Da Silva JF; Cordeiro MN; Vieira LB; Ribeiro FM
    Toxicon; 2016 Mar; 112():16-21. PubMed ID: 26802625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
    Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
    Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
    Spampanato J; Gu X; Yang XW; Mody I
    Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.
    Gu Y; Pope A; Smith C; Carmona C; Johnstone A; Shi L; Chen X; Santos S; Bacon-Brenes CC; Shoff T; Kleczko KM; Frydman J; Thompson LM; Mobley WC; Wu C
    Neurobiol Dis; 2024 Jun; 195():106502. PubMed ID: 38608784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.